164 related articles for article (PubMed ID: 29935260)
1. Targeting redox vulnerability of cancer cells by prooxidative intervention of a glutathione-activated Cu(II) pro-ionophore: Hitting three birds with one stone.
Bao XZ; Dai F; Li XR; Zhou B
Free Radic Biol Med; 2018 Aug; 124():342-352. PubMed ID: 29935260
[TBL] [Abstract][Full Text] [Related]
2. Designing salicylaldehyde isonicotinoyl hydrazones as Cu(II) ionophores with tunable chelation and release of copper for hitting redox Achilles heel of cancer cells.
Ji Y; Dai F; Zhou B
Free Radic Biol Med; 2018 Dec; 129():215-226. PubMed ID: 30240704
[TBL] [Abstract][Full Text] [Related]
3. A hydrogen peroxide-activated Cu(II) pro-ionophore strategy for modifying naphthazarin as a promising anticancer agent with high selectivity for generating ROS in HepG2 cells over in L02 cells.
Bao XZ; Wang Q; Ren XR; Dai F; Zhou B
Free Radic Biol Med; 2020 May; 152():597-608. PubMed ID: 31805398
[TBL] [Abstract][Full Text] [Related]
4. Developing glutathione-activated catechol-type diphenylpolyenes as small molecule-based and mitochondria-targeted prooxidative anticancer theranostic prodrugs.
Bao XZ; Dai F; Wang Q; Jin XL; Zhou B
Free Radic Biol Med; 2019 Apr; 134():406-418. PubMed ID: 30707929
[TBL] [Abstract][Full Text] [Related]
5. Keto-enol-based modification on piperlongumine to generate a potent Cu(II) ionophore that triggers redox imbalance and death of HepG2 cells.
Dai F; Yuan CH; Ji Y; Du YT; Bao XZ; Wu LX; Jin XL; Zhou B
Free Radic Biol Med; 2018 May; 120():124-132. PubMed ID: 29555591
[TBL] [Abstract][Full Text] [Related]
6. Structural basis, chemical driving forces and biological implications of flavones as Cu(II) ionophores.
Dai F; Yan WJ; Du YT; Bao XZ; Li XZ; Zhou B
Free Radic Biol Med; 2017 Jul; 108():554-563. PubMed ID: 28431962
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity.
Zheng CY; Lam SK; Li YY; Ho JC
Int J Oncol; 2015 Mar; 46(3):1067-78. PubMed ID: 25572414
[TBL] [Abstract][Full Text] [Related]
8. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells.
Nagai M; Vo NH; Shin Ogawa L; Chimmanamada D; Inoue T; Chu J; Beaudette-Zlatanova BC; Lu R; Blackman RK; Barsoum J; Koya K; Wada Y
Free Radic Biol Med; 2012 May; 52(10):2142-50. PubMed ID: 22542443
[TBL] [Abstract][Full Text] [Related]
9. A promising redox cycle-based strategy for designing a catechol-type diphenylbutadiene as a potent prooxidative anti-melanoma agent.
Dai F; Du YT; Zheng YL; Zhou B
Free Radic Biol Med; 2019 Jan; 130():489-498. PubMed ID: 30458279
[TBL] [Abstract][Full Text] [Related]
10. Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy.
Kou L; Sun R; Xiao S; Zheng Y; Chen Z; Cai A; Zheng H; Yao Q; Ganapathy V; Chen R
ACS Appl Mater Interfaces; 2019 Jul; 11(30):26722-26730. PubMed ID: 31276364
[TBL] [Abstract][Full Text] [Related]
11. Targeted Manganese doped silica nano GSH-cleaner for treatment of Liver Cancer by destroying the intracellular redox homeostasis.
Tang H; Li C; Zhang Y; Zheng H; Cheng Y; Zhu J; Chen X; Zhu Z; Piao JG; Li F
Theranostics; 2020; 10(21):9865-9887. PubMed ID: 32863964
[No Abstract] [Full Text] [Related]
12. Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution.
Denoyer D; Pearson HB; Clatworthy SA; Smith ZM; Francis PS; Llanos RM; Volitakis I; Phillips WA; Meggyesy PM; Masaldan S; Cater MA
Oncotarget; 2016 Jun; 7(24):37064-37080. PubMed ID: 27175597
[TBL] [Abstract][Full Text] [Related]
13. Copper(II)-Graphitic Carbon Nitride Triggered Synergy: Improved ROS Generation and Reduced Glutathione Levels for Enhanced Photodynamic Therapy.
Ju E; Dong K; Chen Z; Liu Z; Liu C; Huang Y; Wang Z; Pu F; Ren J; Qu X
Angew Chem Int Ed Engl; 2016 Sep; 55(38):11467-71. PubMed ID: 27504861
[TBL] [Abstract][Full Text] [Related]
14. Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer.
Allensworth JL; Evans MK; Bertucci F; Aldrich AJ; Festa RA; Finetti P; Ueno NT; Safi R; McDonnell DP; Thiele DJ; Van Laere S; Devi GR
Mol Oncol; 2015 Jun; 9(6):1155-68. PubMed ID: 25769405
[TBL] [Abstract][Full Text] [Related]
15. Selective induction of oxidative stress in cancer cells via synergistic combinations of agents targeting redox homeostasis.
Akladios FN; Andrew SD; Parkinson CJ
Bioorg Med Chem; 2015 Jul; 23(13):3097-104. PubMed ID: 26022081
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the role of the glutathione redox cycle in Cu(II) toxicity to green algae by a chiral perturbation approach.
Chen H; Chen J; Guo Y; Wen Y; Liu J; Liu W
Aquat Toxicol; 2012 Sep; 120-121():19-26. PubMed ID: 22609738
[TBL] [Abstract][Full Text] [Related]
17. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.
Khan M; Yi F; Rasul A; Li T; Wang N; Gao H; Gao R; Ma T
IUBMB Life; 2012 Sep; 64(9):783-94. PubMed ID: 22837216
[TBL] [Abstract][Full Text] [Related]
18. Copper-redox cycling by coumarin-di(2-picolyl)amine hybrid molecule leads to ROS-mediated DNA damage and apoptosis: A mechanism for cancer chemoprevention.
Khan S; Zafar A; Naseem I
Chem Biol Interact; 2018 Jun; 290():64-76. PubMed ID: 29803612
[TBL] [Abstract][Full Text] [Related]
19. Iodinated chlorin p
Sarbadhikary P; Dube A
Chem Biol Interact; 2017 Nov; 277():137-144. PubMed ID: 28918125
[TBL] [Abstract][Full Text] [Related]
20. Self-Assembled Copper-Amino Acid Nanoparticles for in Situ Glutathione "AND" H
Ma B; Wang S; Liu F; Zhang S; Duan J; Li Z; Kong Y; Sang Y; Liu H; Bu W; Li L
J Am Chem Soc; 2019 Jan; 141(2):849-857. PubMed ID: 30541274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
